// company-profile

Editas Medicine, Inc.

EDIT
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings81Insiders15
// api This Editas Medicine, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares versus 3 sales. Buying was led by Hirsch Andrew.

// 90-day insight

Over the last 90 days, Editas Medicine, Inc. insiders bought $0 (5 transactions) and sold $45K (3 transactions).

  • Most active insider: O'Neill Gilmore Neil with 1 transaction totaling $42K.
  • Largest single sale: $42K by O'Neill Gilmore Neil on Jun 3, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Editas Medicine, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$109.7M
QoQ change
+33.5%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$10.5M
4.2M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$10.4M
4.2M shares
#3
RENAISSANCE TECHNOLOGIES LLC
CIK 1037389
$9.8M
4.0M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Hirsch AndrewEDIT
Award
51,700$0.00$0K
Jun 17, 2026Levy Elliott M.EDIT
Award
51,700$0.00$0K
Jun 17, 2026Scadden DavidEDIT
Award
51,700$0.00$0K
Jun 17, 2026Hopfield JessicaEDIT
Award
51,700$0.00$0K
Jun 17, 2026Connaughton BernadetteEDIT
Award
51,700$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.